Bio-Rad Laboratories, Inc. (BIO): Price and Financial Metrics

BIO POWR Grades

• BIO scores best on the Sentiment dimension, with a Sentiment rank ahead of 94.92% of US stocks.
• The strongest trend for BIO is in Growth, which has been heading down over the past 179 days.
• BIO ranks lowest in Momentum; there it ranks in the 5th percentile.

BIO Stock Summary

• BIO has a market capitalization of $17,419,481,037 -- more than approximately 86.32% of US stocks.
• Bio-Rad Laboratories Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
• With a price/earnings ratio of 4.1, Bio-Rad Laboratories Inc P/E ratio is greater than that of about only 4.11% of stocks in our set with positive earnings.
• Stocks with similar financial metrics, market capitalization, and price volatility to Bio-Rad Laboratories Inc are AGCO, ELSE, MFGP, GENC, and MOG.A.
• Visit BIO's SEC page to see the company's official filings. To visit the company's web site, go to www.bio-rad.com.

BIO Valuation Summary

• In comparison to the median Healthcare stock, BIO's EV/EBIT ratio is 84.64% lower, now standing at 4.5.
• BIO's price/sales ratio has moved up 7.4 over the prior 243 months.
• Over the past 243 months, BIO's price/earnings ratio has gone down 9.8.

Below are key valuation metrics over time for BIO.

BIO Growth Metrics

Its 3 year cash and equivalents growth rate is now at 12.95%.
• The 3 year net cashflow from operations growth rate now stands at 92.94%.
• Its 3 year revenue growth rate is now at 13.58%.

Over the past 34 months, BIO's revenue has gone up $630,670,000.

The table below shows BIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	2,922.545	656.521	4,245.902
2021-09-30	2,979.615	783.331	6,658.663
2021-06-30	2,879.829	688.632	4,045.454
2021-03-31	2,700.778	626.13	4,097.769
2020-12-31	2,545.626	575.328	3,806.267
2020-09-30	2,380.215	450.396	3,520.651

BIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BIO has a Quality Grade of B, ranking ahead of 77.91% of graded US stocks.
• BIO's asset turnover comes in at 0.192 -- ranking 66th of 75 Measuring and Control Equipment stocks.
• AATC, HTGM, and WAT are the stocks whose asset turnover ratios are most correlated with BIO.

The table below shows BIO's key quality metrics over time.